Free Trial
NASDAQ:PRTC

PureTech Health (PRTC) Stock Price, News & Analysis

PureTech Health logo
$17.42 0.00 (0.00%)
As of 11/6/2026

About PureTech Health Stock (NASDAQ:PRTC)

Advanced

Key Stats

Today's Range
$17.42
▼
$17.42
50-Day Range
$17.42
▼
$17.42
52-Week Range
$14.50
▼
$19.92
Volume
N/A
Average Volume
18,480 shs
Market Capitalization
$424.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

PureTech Health plc is a biotherapeutics company that discovers and develops medicines for serious diseases. Founded in 2015, the company advances treatments through a portfolio of wholly owned programs and separately operating companies it has helped establish.

Its research has covered areas including immunology, oncology and neuroscience, using scientific and technology platforms to pursue new therapeutic approaches. PureTech’s work is focused on developing drug candidates rather than providing healthcare services or operating a broad marketed-product business.

One company PureTech founded was Karuna Therapeutics, which developed xanomeline and trospium for schizophrenia. The treatment was approved in the United States as Cobenfy in 2024, after Bristol Myers Squibb acquired Karuna.

AI Generated. May Contain Errors.

Receive PRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRTC Stock News Headlines

PRTC's Gallop to Present Ph1b LYT-200 Data at ESMO
PRTC's SPTX Presents Phase 1 GlyphAgo Data at ECNP
What the hell is going on?
Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and the shift is already underway. The dollar has lost 88% of its purchasing power since it was untethered from gold, and Fortune calls the current change the biggest shift in the world's relationship with the dollar in a generation. Stansberry says a similar reset is planned to be unveiled in Miami as soon as this December. Watch Porter Stansberry's full broadcast to see which companies could be affected.tc pixel
See More Headlines

PRTC Stock Analysis - Frequently Asked Questions

PureTech Health's stock was trading at $17.1150 at the beginning of the year. Since then, PRTC stock has increased by 1.8% and is now trading at $17.42.

Company Calendar

Today
11/16/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:PRTC
CIK
1782999
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.59
Quick Ratio
6.59

Sales & Book Value

Annual Sales
$4.66 million
Price / Sales
91.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$12.65 per share
Price / Book
1.38

Miscellaneous

Outstanding Shares
24,342,000
Free Float
23,052,000
Market Cap
$424.04 million
Optionable
Not Optionable
Beta
1.15

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (NASDAQ:PRTC) was last updated on 11/6/2026 by MarketBeat.com Staff.
From Our Partners